期刊文献+

激发型CD40单抗对宫颈癌细胞株SiHa化疗敏感性的影响 被引量:3

CD40 monoclonal antibody enhances chemosensitivity of human cervical tumor cell line SiHa to chemotherapy
暂未订购
导出
摘要 目的:研究激发型CD40单抗(5C11)对宫颈癌细胞株SiHa化疗敏感性的影响及其机制。方法:采用流式细胞术检测宫颈癌细胞株SiHa上CD40分子的表达,用MTT法检测5C11联合化疗药物对SiHa细胞的作用,PI染色检测SiHa细胞周期的变化,Annexin V-PI法检测细胞凋亡,RT-PCR方法分析单抗5C11作用SiHa细胞后凋亡基因表达水平变化。结果:宫颈癌细胞株SiHa高表达CD40,5C11和盐酸吉西他滨单独抑制细胞生长作用不明显,但两者联合能显著抑制SiHa生长和促进凋亡,SiHa细胞经5C11作用后出现S期阻滞,抗凋亡基因bcl-XL表达明显下调,促凋亡基因Bax的上调作用不明显。结论:CD40分子通过介导S期阻滞和调节凋亡基因表达水平增加SiHa细胞对盐酸吉西他滨化疗的敏感性。 Objective:To study the enhancing effect of CD40 mAb on the chemosensitivity of human cervical tumor cell line SiHa to Gemcitabin.Methods:Flow cytometric analysis was used to detect the expression of CD40 in SiHa.Agonistic anti-human CD40 monoclonal antibody(5C11) was added to the cell culture system.PI staining and Annexin V-PI assay were used to study the biological effect of 5C11 on cervical tumor cell.Cell proliferation was analyzed by MTT assay.Expression of apoptotic genes was evaluated by RT-PCR.Results:The cervical tumor cell line SiHa highly expressed CD40.5C11 or Gemcitabin could not effectively induce SiHa proliferation arrest,but combination of 5C11 and Gemcitabin could do.CD40 activation induced arresting the cells at S phases and down-regulating anti-apoptotic gene bcl-XL expression and up-regulating apoptotic gene Bax expression weakly.Conclusion:CD40 activation can enhance chemosensitivity of human cervical tumor cell to Gemcitabin by inducing arresting the cells at S phases and affecting apoptotic genes expression.
出处 《现代妇产科进展》 CSCD 北大核心 2010年第4期261-264,共4页 Progress in Obstetrics and Gynecology
关键词 宫颈肿瘤 抗原 CD40 抗体 单克隆 细胞系 化疗敏感性 Cervical neoplasms Antigens CD40 Antibodies monoclonal Cell line Chemotherapy sensitivity
  • 相关文献

参考文献10

  • 1Fabrini MG, Gadducci A, Perrone F, et al. Clinical outcome of tailored adjuvant postoperative chemoradiotherapy in IB FIGO stage cervical cancer[J]. Anticance Res, 2009,29 : 4205-4210.
  • 2Law CL, Gordon KA, Collier J, et al. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal anti-body, SGN-40 [ J ]. Cancer Res, 2005,65 : 8331-8338.
  • 3Zhou ZH, Wang JF, Wang YD, et al. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line[ J]. Hybridoma, 1999,18:471-478.
  • 4Zhou ZH, Shi Q, Wang JF, et al. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and γ- radiation-induced apoptosis by CD40 activation[ J ]. Apoptosis ,2005,10 : 123-134.
  • 5Qu QX, Ge Y, Chen Y J, et al. Preparation and characterization of a novel chimeric antibody against human CD40 with the potential to inhibit daudi cell proliferation [ J ]. Hybridoma ,2009,28 : 121-128.
  • 6Groeger AM,Esposito V, De Luca A, et al. Prognostic value of immunohistochemical expression of p53, Bax, Bcl-2 and Bcl-xL in resected non-small cell lung cancers [ J]. Histopathology, 2004,44 : 54 -63.
  • 7Zhao DL, Shi JS,Li MZ, et al. The expression of apoptosis related genes bcl-2 and bax protein and apoptosis positivity in cervical carcinoma during irradiation[ J ]. J Clin Oncol ,2005,4 : 105-107.
  • 8向梅,吕荣军,崔丽晶,胡杰,上访敏子.宫颈鳞状细胞癌化疗前后Bcl-2、VEGF变化与疗效的关系[J].中国实用妇科与产科杂志,2009,25(4):290-292. 被引量:1
  • 9魏玮,程玉峰,姜玉华,梁业民,乔乃安.Bax、Bcl-2ASODN联合转染增强宫颈癌HeLa细胞放射敏感性的实验研究[J].现代妇产科进展,2006,15(11):841-843. 被引量:9
  • 10Hernandez P, Olivera P, Duenas-Gonzalez A, et al. Gemcitabine activity in cancer cell lines [ J ]. Cancer Chemother Pharmacol,2001,48 :488-492.

二级参考文献18

  • 1曾静,王和.宫颈癌放疗敏感性的研究进展[J].现代妇产科进展,2005,14(6):498-501. 被引量:5
  • 2胡秀峰,周芳.血清TSP-1、VEGF对评价食管癌患者化疗疗效的意义[J].实用癌症杂志,2007,22(1):37-40. 被引量:5
  • 3平林光司 岗田悦子 中妻嘉夫 等.SIP治疗浸润、再发宫颈癌的临床研究.日本妇产科杂志,1992,44:341-348.
  • 4对木章 大谷贵美 铃木卓 等.宫颈癌术前硫酸培洛霉素,异环磷酰胺,奈得铂疗法.日本妇产科杂志,2002,54:633-637.
  • 5Hwang YY, Moon H , Cho SH , et al. Ten-year survival of patients with locally advanced stage Ⅰb2 and Ⅱb cervical cancer after neoadjuvant chemotherapy and radical hysterectomy [ J] . Gynecol Oncol , 2001 , 82 (4) :402-408.
  • 6Huang HJ , Chang TC , Hong JH , et al . Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky ( ≥ 4 cm) stage Ⅰb and Ⅱa cervical carcinoma[J]. Int J Gynecol'Cancer , 2003 , 13 : 204-211.
  • 7Bolis G, van Zainten PI, Scarfone G, et al. Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage Ⅰb - Ⅱa invasive cervical cancer[ J] . Gynecol Oncol , 1996 , 63 : 62-65.
  • 8Reed JC. Bcl-2 and the regulation of programmed cell death[ J]. J Cell Biol, 1993,75(2) :241-243.
  • 9高岩,彭芝兰.宫颈鳞癌及新辅助化疗对血清VEGF表达的影响[J].华西医学,2007,22(3):513-514. 被引量:2
  • 10聂林 张洹 李萍 等.Bcl—2和bax蛋白表达与鼻咽癌放射敏感性相关关系的探讨[J].中华放射肿瘤学杂志,2005,14:112-115.

共引文献8

同被引文献48

  • 1瞿秋霞,陈永井,葛彦,王勤,陈成,杨明峰,张学光.抗人CD40人-鼠嵌合抗体的构建及其表达[J].细胞与分子免疫学杂志,2006,22(2):189-192. 被引量:10
  • 2Elgueta R, Benson MJ, de Vries VC, et al. Molecular mechanism and function of CIM0/CD154 engagement in the immune system [ J ]. Immunol Rev, 2009, 229 ( 1 ) : 152-172.
  • 3Donners M, Beckers L, Lievens D, et al. The CD40-TRAF6 axis is the key regulator of the CIM0/CIMOL system in neointima formation and arterial remodeling [ J ]. Blood, 2008, 111 ( 9 ) : 4596-4604.
  • 4Loskog A, Eliopoulos AG. The Janus faces of CD40 in cancer [J]. Semin Immunol, 2009, 21 (5) : 301-307.
  • 5Xie F, Shi Q, Wang Q, et al. CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma [J]. J Neuroimmunol, 2010, 222(1/2): 62-69.
  • 6Noguchi M, Imaizumi K, Kawabe T, et al. induction of antitumor immunity by transduction of CDd-0 ligand and interferon-gamma gene into lung cancer [J]. Cancer Gene Ther, 2001, 8(6) : 421- 429.
  • 7Tong AW, Papayoti MH, Netto G, et al. Growth-inhibitory effects of CD40 ligand and its endogenous expression in human breast cancer [J]. Clin Cancer Res, 2001, 7(3) : 691-703.
  • 8Loskog A, Bjokland A, Brown MP, et al. Potent antitumor effects of CD154 transduced tumor cells in experimental bladder cancer [J]. J Urol, 2001, 166(3) : 1093-1097.
  • 9Schmitz V, Barajas M, Wang L, et al. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma [J]. Hepatology, 2001, 34(1 ): 72-81.
  • 10Zhou ZH, Waag JF, Wang YD, et al. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line [J]. Hybridoma, 1999, 18(6) : 471-478.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部